|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-5-5
|
|
pubmed:abstractText |
Patients with invasive lobular carcinoma (ILC) experience a lower pathological complete response rate to neoadjuvant chemotherapy than patients with invasive ductal carcinoma. This study was intended to evaluate the impact of neoadjuvant chemotherapy in ILC on breast-conserving surgery (BCS) rates.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1534-4681
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1606-11
|
|
pubmed:meshHeading |
pubmed-meshheading:19280264-Adult,
pubmed-meshheading:19280264-Aged,
pubmed-meshheading:19280264-Aged, 80 and over,
pubmed-meshheading:19280264-Antineoplastic Agents,
pubmed-meshheading:19280264-Breast Neoplasms,
pubmed-meshheading:19280264-Carcinoma, Lobular,
pubmed-meshheading:19280264-Chemotherapy, Adjuvant,
pubmed-meshheading:19280264-Female,
pubmed-meshheading:19280264-Humans,
pubmed-meshheading:19280264-Mastectomy,
pubmed-meshheading:19280264-Mastectomy, Segmental,
pubmed-meshheading:19280264-Middle Aged,
pubmed-meshheading:19280264-Neoadjuvant Therapy,
pubmed-meshheading:19280264-Retrospective Studies
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation.
|
|
pubmed:affiliation |
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, USA.
|
|
pubmed:publicationType |
Journal Article
|
